NCT02392442
Effects of Bronchial Segmental Endotoxin Instillation in Humans
Enrolling by Invitation
PHASE2Ages 18–45InterventionalBasic scienceNational Institutes of Health Clinical Center (CC)Government-funded
~58 participants
Updated 2026-09-16 on ClinicalTrials.gov
What's tested:SalineEndotoxin
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Identification of cell-associated and secreted miRNA with specific types of resident and inflammatory cells in the lung.
Measured over 6, 24, or 48 hours after Endotoxin is instilled in the lung.
Conditions
NCT02392442
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
National Institutes of Health Clinical Center
Bethesda, Marylandno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Anthony F Suffredini, M.D. · PRINCIPAL_INVESTIGATOR · National Institutes of Health Clinical Center (CC)
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Identification of cell-associated and secreted miRNA with specific types of resident and inflammatory cells in the lung.6, 24, or 48 hours after Endotoxin is instilled in the lung.
Identification of cell-associated and secreted miRNA.